Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Methylene Blue vs Primaquine with AS-AQ in Children with Malaria
NCT02851108Phase 2Completed
- Sponsor
- Heidelberg University
- Start
- Oct 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of methylene blue in Malaria (2 arms), sponsored by Heidelberg University. Primary endpoint: Change in Haemoglobin Compared to the Baseline at 7 days. Started Oct 2016; status: completed.
02
Drugs
methylene blue
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT02851108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02851108.